Beware of fraudulent websites and e-mails for ESHRE 2023

06 June 2023

Please be vigilant for fraudulent websites and e-mails. As a reminder, ESHRE will never allow third-party vendors access to your information. ESHRE also does not solicit third-party vendors to sell registration or accommodation services.

ESHRE guideline on the number of embryos to transfer during IVF/ICSI is now open for stakeholder review

12 May 2023

The ESHRE guideline on the number of embryos to transfer during IVF/ICSI has been developed to provide infertility care practitioners with the best available evidence and recommendations on how many embryos to transfer during IVF/ICSI and is now open for stakeholder review.

Send us your comments and suggestions before 23 June 2023. .

Embryos’ development is delayed in pregnancies that end in miscarriage

27 March 2023

Human Reproduction Press Release
Embryos in pregnancies that end in miscarriage take longer to develop in the womb than those in pregnancies that result in live births.

Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma

02 March 2023

A comprehensive guide on how to approach fertility-sparing treatment in endometrial cancer, written in an international collaboration with leading experts from ESHRE, the European Society of Gynaecological Oncology (ESGO) and the European Society for Gynaecological Endoscopy (ESGE) is now published in Human Reproduction Open, and simultaneously in the International Journal of Gynecological Cancer, and Facts, Views, & Vision in ObGyn.